US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Sionna Therapeutics

6.88

-1.3800-16.71%

Post-market: 6.900.0204+0.30%19:58 EDT

Volume:2.46M

Turnover:17.48M

Market Cap:309.59M

PE:-3.17

High:8.00

Open:7.87

Low:6.85

Close:8.26

52wk High:54.97

52wk Low:4.01

Shares:45.00M

Float Shares:16.73M

Volume Ratio:2.32

T/O Rate:14.72%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1683

EPS(LYR):-1.8835

ROE:-32.34%

ROA:-21.54%

PB:1.16

PE(LYR):-3.65

Loading ...

Overview Company News Filings

Top Premarket Decliners

MT Newswires Live

Sionna Falls After Experimental Drug Misses Mid-Stage Trial Goal

Sionna Therapeutics Says SION-719 Phase 2a Trial Misses Sweat Chloride Endpoint in Cystic Fibrosis

Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update

THOMSON REUTERS

Sionna Therapeutics, - Evaluating Sion-719 Trial Confounders to Inform Sion-451 Program Next Steps

THOMSON REUTERS

Sionna Therapeutics, - Ends Q2 with $268.30 Mln in Cash; Plans Capital Preservation Actions

THOMSON REUTERS

Sionna Therapeutics, - Sion-719 Phase 2a Trial Does not Meet Key Endpoint; Program Discontinued as Add-on

THOMSON REUTERS

RBC Capital Remains a Sell on Sionna Therapeutics, Inc. (SION)

Sionna Therapeutics is Maintained at Buy by Guggenheim

Sionna Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Sionna Therapeutics Q2 EPS $(0.66) Misses $(0.65) Estimate

Benzinga Earnings

Sionna Net Loss Widens 65.43% to $29.89 Million in Q2 FY26

Sionna Therapeutics Inc Q2 Basic EPS USD -0.66

THOMSON REUTERS

Sionna Therapeutics Inc Q2 Operating Expenses USD 32.47 Million

THOMSON REUTERS

Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says

MT Newswires Live

Guggenheim Keeps Their Buy Rating on Sionna Therapeutics, Inc. (SION)

Sionna Therapeutics, Inc. (SION) Receives a Rating Update from a Top Analyst

Sionna Therapeutics (SION) Stock Looks Pricey On Assets But Strong On Returns

Simply Wall St.

Sionna Therapeutics rises 9.2%

Orbimed Advisors Disposes of 85,918 Sionna Therapeutics Shares Worth $3.85 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/SION/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"SION","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SION\",,,,,undefined,":{"symbol":"SION","market":"US","secType":"STK","nameCN":"Sionna Therapeutics","latestPrice":6.88,"timestamp":1789502400000,"preClose":8.26,"halted":0,"volume":2462370,"hourTrading":{"tag":"盘后","latestPrice":6.9004,"preClose":6.88,"latestTime":"19:58 EDT","volume":9395,"amount":64941.0198,"timestamp":1789516689602,"change":0.0204,"changeRate":0.002965,"amplitude":0.010174},"delay":0,"changeRate":-0.16707021791767554,"floatShares":16725500,"shares":44998073,"eps":-2.16827,"marketStatus":"Not Yet Opened","change":-1.38,"latestTime":"09-15 16:00:00 EDT","open":7.87,"high":8,"low":6.85,"amount":17475474.36318,"amplitude":0.139225,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.16827,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"listingDate":1738904400000,"exchange":"NASDAQ","adjPreClose":8.26,"preHourTrading":{"tag":"盘前","latestPrice":7.89,"preClose":8.26,"latestTime":"09:28 EDT","volume":5041,"amount":41063.708744999996,"timestamp":1789478897506,"change":-0.37,"changeRate":-0.044794,"amplitude":0.05569},"postHourTrading":{"tag":"盘后","latestPrice":6.9004,"preClose":6.88,"latestTime":"19:58 EDT","volume":9395,"amount":64941.0198,"timestamp":1789516689602,"change":0.0204,"changeRate":0.002965,"amplitude":0.010174},"volumeRatio":2.321127,"impliedVol":1.784,"impliedVolPercentile":0.6905},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SION\",,,,,undefined,":{"symbol":"SION","floatShares":16725500,"roa":"-21.54%","roe":"-32.34%","lyrEps":-1.883481,"volumeRatio":2.321127,"shares":44998073,"dividePrice":0,"high":8,"amplitude":0.139225,"preClose":8.26,"low":6.85,"week52Low":4.01,"pbRate":"1.16","week52High":54.97,"institutionHeld":0,"latestPrice":6.88,"eps":-2.16827,"divideRate":0,"volume":2462370,"delay":0,"ttmEps":-2.16827,"open":7.87,"prevYearClose":41.14,"prevWeekClose":7.85,"prevMonthClose":6.03,"prevQuarterClose":43.99,"fiveDayClose":7.3,"twentyDayClose":5.91,"sixtyDayClose":37.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SION\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"SION","fiscalQuarterEnding":"2026/06","expectedEps":-0.64,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.66},{"market":"US","date":"2026-05-12","symbol":"SION","fiscalQuarterEnding":"2026/03","expectedEps":-0.52,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"pre","actualEps":-0.6},{"market":"US","date":"2026-03-02","symbol":"SION","fiscalQuarterEnding":"2025/12","expectedEps":-0.61,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772427600000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2025-11-05","symbol":"SION","fiscalQuarterEnding":"2025/09","expectedEps":-0.52,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2025-08-11","symbol":"SION","fiscalQuarterEnding":"2025/06","expectedEps":-0.68,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.41}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SION\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SION\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.0909,"hold":0.9091,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.9091,"analysts":11,"updateTime":1786593600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SION\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SION","date":"2026-09-14","current":-3.20532,"percent":0.9425,"low":-28.087165,"twenty":-23.967327,"median":-17.990242,"eighty":-9.792634,"high":-2.089233,"avg":-17.189294,"sd":7.204562,"marketCap":354917332},"quantilePoints":[{"date":"2025-02-07","current":-13.261013,"twenty":-12.252025,"median":-10.738543,"eighty":-9.22506,"marketCap":765372600},{"date":"2025-02-14","current":-14.940741,"twenty":-16.115077,"median":-14.940741,"eighty":-13.535074,"marketCap":862319796},{"date":"2025-02-21","current":-15.365065,"twenty":-15.365065,"median":-14.763927,"eighty":-14.631317,"marketCap":886810118},{"date":"2025-02-28","current":-11.280197,"twenty":-15.101402,"median":-14.760244,"eighty":-13.045594,"marketCap":651047865},{"date":"2025-03-07","current":-11.960372,"twenty":-15.059369,"median":-14.631317,"eighty":-11.310767,"marketCap":690304817},{"date":"2025-03-14","current":-13.068521,"twenty":-15.036515,"median":-13.072343,"eighty":-11.387191,"marketCap":754262771},{"date":"2025-03-21","current":-10.607665,"twenty":-14.940741,"median":-12.594692,"eighty":-11.280197,"marketCap":612232003},{"date":"2025-03-28","current":-8.569094,"twenty":-14.763927,"median":-12.189644,"eighty":-10.607665,"marketCap":528610240},{"date":"2025-04-04","current":-8.304439,"twenty":-14.75656,"median":-11.44833,"eighty":-8.654927,"marketCap":512284214},{"date":"2025-04-11","current":-5.47907,"twenty":-14.719724,"median":-11.345158,"eighty":-8.304439,"marketCap":337992858},{"date":"2025-04-17","current":-7.152833,"twenty":-14.648998,"median":-11.146455,"eighty":-7.438946,"marketCap":441243940},{"date":"2025-04-25","current":-9.012569,"twenty":-13.535074,"median":-10.607665,"eighty":-7.830921,"marketCap":555967364},{"date":"2025-05-02","current":-9.227154,"twenty":-13.113134,"median":-10.157913,"eighty":-8.049798,"marketCap":569204682},{"date":"2025-05-09","current":-8.991111,"twenty":-13.07005,"median":-9.363058,"eighty":-8.189398,"marketCap":554643632},{"date":"2025-05-16","current":-8.935031,"twenty":-13.050179,"median":-9.227154,"eighty":-8.189398,"marketCap":592598052},{"date":"2025-05-23","current":-8.649163,"twenty":-12.684872,"median":-9.227154,"eighty":-8.258154,"marketCap":573638442},{"date":"2025-05-30","current":-9.380453,"twenty":-12.498397,"median":-9.212848,"eighty":-8.290133,"marketCap":622139770},{"date":"2025-06-06","current":-10.656886,"twenty":-12.42503,"median":-9.227154,"eighty":-8.395596,"marketCap":706796635},{"date":"2025-06-13","current":-11.295102,"twenty":-12.251212,"median":-9.28738,"eighty":-8.459628,"marketCap":749125067},{"date":"2025-06-20","current":-9.792634,"twenty":-12.067794,"median":-9.313972,"eighty":-8.462287,"marketCap":649476883},{"date":"2025-06-27","current":-9.859115,"twenty":-11.920631,"median":-9.377129,"eighty":-8.491142,"marketCap":653886095},{"date":"2025-07-03","current":-14.087299,"twenty":-12.050418,"median":-9.569923,"eighty":-8.540482,"marketCap":934311959},{"date":"2025-07-11","current":-13.921097,"twenty":-12.562594,"median":-9.646376,"eighty":-8.576247,"marketCap":923288929},{"date":"2025-07-18","current":-12.185946,"twenty":-12.955414,"median":-9.792431,"eighty":-8.606288,"marketCap":808208504},{"date":"2025-07-25","current":-12.724441,"twenty":-12.981363,"median":-9.952188,"eighty":-8.61201,"marketCap":843923119},{"date":"2025-08-01","current":-11.142196,"twenty":-12.981363,"median":-10.527086,"eighty":-8.61201,"marketCap":738983880},{"date":"2025-08-08","current":-11.487897,"twenty":-12.719123,"median":-10.607665,"eighty":-8.619441,"marketCap":761911781},{"date":"2025-08-15","current":-12.17004,"twenty":-12.719123,"median":-10.776552,"eighty":-8.650316,"marketCap":922963698},{"date":"2025-08-22","current":-13.817157,"twenty":-12.981363,"median":-10.951574,"eighty":-8.660649,"marketCap":1047879398},{"date":"2025-08-29","current":-14.969557,"twenty":-13.185819,"median":-11.135548,"eighty":-8.685971,"marketCap":1135276247},{"date":"2025-09-05","current":-13.421384,"twenty":-13.261013,"median":-11.264381,"eighty":-8.6957,"marketCap":1017864318},{"date":"2025-09-12","current":-13.849168,"twenty":-13.582045,"median":-11.295102,"eighty":-8.81229,"marketCap":1050307088},{"date":"2025-09-19","current":-13.520327,"twenty":-13.543608,"median":-11.380538,"eighty":-8.928383,"marketCap":1025368088},{"date":"2025-09-26","current":-16.005553,"twenty":-13.817157,"median":-11.448008,"eighty":-8.935031,"marketCap":1213845132},{"date":"2025-10-03","current":-17.053189,"twenty":-13.934393,"median":-11.481249,"eighty":-8.974919,"marketCap":1293296813},{"date":"2025-10-10","current":-16.50027,"twenty":-14.087299,"median":-11.594266,"eighty":-8.991111,"marketCap":1251363982},{"date":"2025-10-17","current":-19.043698,"twenty":-14.329335,"median":-11.773765,"eighty":-9.012569,"marketCap":1444255008},{"date":"2025-10-24","current":-23.047996,"twenty":-14.678547,"median":-11.960372,"eighty":-9.101233,"marketCap":1747936990},{"date":"2025-10-31","current":-22.122584,"twenty":-14.777491,"median":-12.128534,"eighty":-9.127014,"marketCap":1677754672},{"date":"2025-11-07","current":-21.722088,"twenty":-15.059369,"median":-12.17004,"eighty":-9.148473,"marketCap":1535230307},{"date":"2025-11-14","current":-22.656643,"twenty":-15.557397,"median":-12.201274,"eighty":-9.173508,"marketCap":1601280913},{"date":"2025-11-21","current":-24.588899,"twenty":-16.50027,"median":-12.318908,"eighty":-9.207602,"marketCap":1737845004},{"date":"2025-11-28","current":-27.51254,"twenty":-16.690008,"median":-12.434201,"eighty":-9.211799,"marketCap":1944476293},{"date":"2025-12-05","current":-25.813923,"twenty":-17.070649,"median":-12.542534,"eighty":-9.224293,"marketCap":1824424853},{"date":"2025-12-12","current":-26.344347,"twenty":-17.43383,"median":-12.644664,"eighty":-9.227154,"marketCap":1861913035},{"date":"2025-12-19","current":-27.916672,"twenty":-18.615331,"median":-12.828464,"eighty":-9.244321,"marketCap":1973038717},{"date":"2025-12-26","current":-27.799853,"twenty":-20.840976,"median":-13.015231,"eighty":-9.271873,"marketCap":1964782391},{"date":"2026-01-02","current":-25.978102,"twenty":-21.880226,"median":-13.072343,"eighty":-9.298017,"marketCap":1836028338},{"date":"2026-01-09","current":-23.111292,"twenty":-22.280894,"median":-13.196456,"eighty":-9.333606,"marketCap":1633413640},{"date":"2026-01-16","current":-24.532068,"twenty":-22.755262,"median":-13.25865,"eighty":-9.367357,"marketCap":1733828413},{"date":"2026-01-23","current":-26.375919,"twenty":-23.010449,"median":-13.309024,"eighty":-9.375135,"marketCap":1864144474},{"date":"2026-01-30","current":-26.798995,"twenty":-23.217376,"median":-13.467945,"eighty":-9.407045,"marketCap":1894045762},{"date":"2026-02-06","current":-22.258826,"twenty":-24.10394,"median":-13.562826,"eighty":-9.536018,"marketCap":1573164777},{"date":"2026-02-13","current":-23.768006,"twenty":-23.957443,"median":-13.817157,"eighty":-9.627762,"marketCap":1679827580},{"date":"2026-02-20","current":-23.578569,"twenty":-24.004802,"median":-13.914449,"eighty":-9.63308,"marketCap":1666438943},{"date":"2026-02-27","current":-23.99533,"twenty":-24.004802,"median":-13.951438,"eighty":-9.646376,"marketCap":1695893944},{"date":"2026-03-06","current":-20.661282,"twenty":-23.99533,"median":-14.087299,"eighty":-9.713547,"marketCap":1555133402},{"date":"2026-03-13","current":-21.928699,"twenty":-23.824837,"median":-14.227481,"eighty":-9.792228,"marketCap":1650529317},{"date":"2026-03-20","current":-21.217272,"twenty":-23.768006,"median":-14.329335,"eighty":-9.792634,"marketCap":1596981610},{"date":"2026-03-27","current":-22.693932,"twenty":-23.692231,"median":-14.628741,"eighty":-9.859115,"marketCap":1708126851},{"date":"2026-04-02","current":-24.690711,"twenty":-23.779372,"median":-14.699136,"eighty":-9.933573,"marketCap":1858420414},{"date":"2026-04-10","current":-23.249921,"twenty":-23.779372,"median":-14.763927,"eighty":-10.393622,"marketCap":1749975058},{"date":"2026-04-17","current":-27.046193,"twenty":-23.997224,"median":-14.955149,"eighty":-10.519675,"marketCap":2035712822},{"date":"2026-04-24","current":-22.927089,"twenty":-24.052712,"median":-15.059369,"eighty":-10.529177,"marketCap":1725676099},{"date":"2026-05-01","current":-23.210503,"twenty":-24.014274,"median":-15.233234,"eighty":-10.592246,"marketCap":1747008171},{"date":"2026-05-08","current":-25.975372,"twenty":-24.255396,"median":-15.761105,"eighty":-10.607665,"marketCap":1955114312},{"date":"2026-05-15","current":-22.568569,"twenty":-24.314473,"median":-16.442494,"eighty":-10.647042,"marketCap":1931079614},{"date":"2026-05-22","current":-22.030343,"twenty":-24.255396,"median":-16.587573,"eighty":-10.662204,"marketCap":1885026277},{"date":"2026-05-29","current":-22.584399,"twenty":-24.225568,"median":-16.843662,"eighty":-10.799155,"marketCap":1932434124},{"date":"2026-06-05","current":-19.935481,"twenty":-24.091149,"median":-17.056099,"eighty":-10.92148,"marketCap":1705779467},{"date":"2026-06-12","current":-19.022607,"twenty":-24.014274,"median":-17.123032,"eighty":-10.948046,"marketCap":1627669396},{"date":"2026-06-18","current":-19.381425,"twenty":-24.010485,"median":-17.425682,"eighty":-10.97603,"marketCap":1658371620},{"date":"2026-06-26","current":-22.568569,"twenty":-24.001013,"median":-17.729808,"eighty":-11.059188,"marketCap":1931079614},{"date":"2026-07-02","current":-21.972299,"twenty":-23.989729,"median":-17.973475,"eighty":-11.131559,"marketCap":1880059741},{"date":"2026-07-10","current":-23.713619,"twenty":-23.938829,"median":-18.418073,"eighty":-11.16347,"marketCap":2029055830},{"date":"2026-07-17","current":-23.898305,"twenty":-23.898305,"median":-18.702419,"eighty":-11.254892,"marketCap":2044858445},{"date":"2026-07-24","current":-23.249267,"twenty":-23.989729,"median":-18.996224,"eighty":-11.281848,"marketCap":1989323539},{"date":"2026-07-31","current":-24.684537,"twenty":-24.004802,"median":-19.043698,"eighty":-11.288454,"marketCap":2112132437},{"date":"2026-08-07","current":-23.001015,"twenty":-24.109374,"median":-19.37351,"eighty":-11.295102,"marketCap":2239907871},{"date":"2026-08-14","current":-3.036352,"twenty":-24.014274,"median":-19.249507,"eighty":-11.248566,"marketCap":295689089},{"date":"2026-08-21","current":-2.562793,"twenty":-24.014274,"median":-19.009416,"eighty":-10.951574,"marketCap":249572442},{"date":"2026-08-28","current":-2.813501,"twenty":-24.004802,"median":-18.741047,"eighty":-10.656886,"marketCap":273987137},{"date":"2026-09-04","current":-3.13385,"twenty":-23.99533,"median":-18.500988,"eighty":-10.523599,"marketCap":305183693},{"date":"2026-09-11","current":-3.537768,"twenty":-23.972928,"median":-18.163438,"eighty":-9.845819,"marketCap":344518480},{"date":"2026-09-14","current":-3.644551,"twenty":-23.967327,"median":-17.990242,"eighty":-9.792634,"marketCap":354917332}],"updateTime":1789500038437},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SION\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658933672","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2658933672","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658933672?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:28","pubTimestamp":1786361331,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics (SION) shares were down more than 92% premarket Monday after the company said that a phase 2a proof-of-concept trial for its cystic fibrosis drug, SION-719, failed to meet its prim","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AIRS","SION","BK4209","BK4139","BK4183","TENX","MB","DSY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658933368","title":"Sionna Falls After Experimental Drug Misses Mid-Stage Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2658933368","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658933368?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:24","pubTimestamp":1786361066,"startTime":"0","endTime":"0","summary":"BUZZ-Sionna falls after experimental drug misses mid-stage trial goal** Shares of biotech firm Sionna TherapeuticsSION.Oshares plunge 92% to $3.99 premarket** Co says experimental cystic fibrosis drug","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470NN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658383659","title":"Sionna Therapeutics Says SION-719 Phase 2a Trial Misses Sweat Chloride Endpoint in Cystic Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2658383659","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658383659?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:01","pubTimestamp":1786359713,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics says SION-719 Phase 2a trial misses sweat chloride endpoint in cystic fibrosisSionna Therapeutics reported topline results from a Phase 2a cystic fibrosis trial of SION-719 added t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL3Nzhyb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","SION","SG9999014039.USD","SG9999014013.SGD","IE00BN0W2T93.GBP","LU2095319765.USD","BK4588","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4585","IE00BGHQF748.EUR","BCDF","IE00BKPKM429.USD","LU0314104364.USD","BK4112","SG9999014005.SGD","IE00B64PRP62.GBP","LU2210150020.SGD","BK4139","NDAQ","IE00BN0W2W23.USD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658980081","title":"Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2658980081","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658980081?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA1SGBDP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658980078","title":"Sionna Therapeutics, - Evaluating Sion-719 Trial Confounders to Inform Sion-451 Program Next Steps","url":"https://stock-news.laohu8.com/highlight/detail?id=2658980078","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658980078?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA1SGBDP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938855","title":"Sionna Therapeutics, - Ends Q2 with $268.30 Mln in Cash; Plans Capital Preservation Actions","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938855","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658938855?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA1SGBDP:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658800349","title":"Sionna Therapeutics, - Sion-719 Phase 2a Trial Does not Meet Key Endpoint; Program Discontinued as Add-on","url":"https://stock-news.laohu8.com/highlight/detail?id=2658800349","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658800349?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA1SGBDP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657622938","title":"RBC Capital Remains a Sell on Sionna Therapeutics, Inc. (SION)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657622938","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657622938?lang=en_us&edition=fundamental","pubTime":"2026-08-08 09:45","pubTimestamp":1786153555,"startTime":"0","endTime":"0","summary":"In a report released on August 6, Brian Abrahams from RBC Capital maintained a Sell rating on Sionna Therapeutics, Inc., with a price target of $23...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-sell-on-sionna-therapeutics-inc-sion-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-sell-on-sionna-therapeutics-inc-sion-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSIB","LU0128525929.USD","LU1267930573.SGD","BK4207","LU0708994859.HKD","LU0310800379.SGD","LU0029864427.USD","BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657628681","title":"Sionna Therapeutics is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2657628681","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657628681?lang=en_us&edition=fundamental","pubTime":"2026-08-08 01:21","pubTimestamp":1786123260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SION/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657390632","title":"Sionna Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657390632","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657390632?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:21","pubTimestamp":1786022486,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings SummarySionna Therapeutics, Inc.SION.OQreported a quarterly adjusted loss of 66 cents per share for the quarter ended","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4431TZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657063550","title":"Sionna Therapeutics Q2 EPS $(0.66) Misses $(0.65) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657063550","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657063550?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:39","pubTimestamp":1786016376,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics (NASDAQ:SION) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimate of $(0.65) by 1.54 percent. This is a 60.98 percent decrease over losses of $(0.41) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60989946/sionna-therapeutics-q2-eps-0-66-misses-0-65-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657382633","title":"Sionna Net Loss Widens 65.43% to $29.89 Million in Q2 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2657382633","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657382633?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:17","pubTimestamp":1786015029,"startTime":"0","endTime":"0","summary":"Sionna net loss widens 65.43% to $29.89 million in Q2 FY26Sionna Therapeutics posted a Q2 net loss of USD 29.9 million, widening from USD 18.1 million a year earlier.R&D expense climbed to USD 21.9 mi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL1Gv04k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657680265","title":"Sionna Therapeutics Inc Q2 Basic EPS USD -0.66","url":"https://stock-news.laohu8.com/highlight/detail?id=2657680265","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657680265?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:00","pubTimestamp":1786014005,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXQHVW7V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657680210","title":"Sionna Therapeutics Inc Q2 Operating Expenses USD 32.47 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657680210","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657680210?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:00","pubTimestamp":1786014005,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXQHVW7V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657255048","title":"Vertex Pharmaceuticals' Solid Q2, Raised Outlook Underscore Core Business Strength, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2657255048","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657255048?lang=en_us&edition=fundamental","pubTime":"2026-08-05 00:02","pubTimestamp":1785859337,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals  reported a solid Q2 and raised its outlook, highlighting the strength of its core business and pipeline, RBC Capital Markets said in a note emailed Tuesday.The analysts said the stock could benefit once the Sionna Therapeutics  data overhang clears, with upcoming catalysts including the launch of new products, the expected closing of the Crinetics Pharmaceuticals  deal, and additional pipeline readouts.The stock does not fully reflect the potential upside from pipeline opportunities, including kidney programs, expansion of povetacicept into autoimmune diseases such as IgA nephropathy and generalized myasthenia gravis, and the longer-term potential of suzetrigine in chronic pain, the analysts added.\"We believe that given Vertex's strong core revenue, a pipeline that is increasingly becoming more mature, and with optionality to further diversify pipeline with external [business development,] shares should command a higher valuation,\" the analysts said.RBC lowered ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","VERX","IE00B2B36J28.USD","BK4588","IE0002270589.USD","IE00BJJMRZ35.SGD","LU1093756325.SGD","LU2237438978.USD","VRTX","GNMX","LU2456880835.USD","PBE","LU1035775433.USD","LU2236285917.USD","LU2362541513.USD","LU1585245621.USD","IE0009355771.USD","LU1674673691.USD","LU2362540622.SGD","LU2324357040.USD","BK4533","LU0234570918.USD","IE00BZ9MQY76.HKD","TBXU","LU2468319806.SGD","IBB","BK4139","LU0256863811.USD","BK4532","IE00B19Z3B42.SGD","LU1778281490.HKD","LU1430594728.SGD","SGXZ57979304.SGD","BIB","LU0417517546.SGD","LU1674673428.USD","LU1815336091.USD","BK4567","IE00B19Z9Z06.USD","LU0061475181.USD","IBBQ","SION","LU0432979614.USD","IDNA","LU0566484027.USD","CRNX","BK4585","LU0823416689.USD","BBH","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654012448","title":"Guggenheim Keeps Their Buy Rating on Sionna Therapeutics, Inc. (SION)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654012448","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654012448?lang=en_us&edition=fundamental","pubTime":"2026-07-27 19:37","pubTimestamp":1785152258,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Yatin Suneja reiterated a Buy rating on Sionna Therapeutics, Inc. on July 24 and set a price target of $50.00. The company’s sha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-keeps-their-buy-rating-on-sionna-therapeutics-inc-sion-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-keeps-their-buy-rating-on-sionna-therapeutics-inc-sion-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652216154","title":"Sionna Therapeutics, Inc. (SION) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2652216154","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652216154?lang=en_us&edition=fundamental","pubTime":"2026-07-20 21:15","pubTimestamp":1784553345,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Ritu Baral maintained a Buy rating on Sionna Therapeutics, Inc. on July 17 and set a price target of $49.41. The company’s shares ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sionna-therapeutics-inc-sion-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sionna-therapeutics-inc-sion-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652255498","title":"Sionna Therapeutics (SION) Stock Looks Pricey On Assets But Strong On Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2652255498","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652255498?lang=en_us&edition=fundamental","pubTime":"2026-07-19 11:27","pubTimestamp":1784431621,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics stock has delivered a sharp 195.2% return over the past year, yet its low value score and overvalued reading on the market multiples raise questions about how much upside is already reflected in the price.\n\nOver the past 1 year, Sionna Therapeutics has returned 195.2%, which puts the recent share price strength firmly in focus for anyone thinking about valuation.\nExpectations for the company’s drug pipeline can support a premium, but uncertainty around execution,...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sion/sionna-therapeutics/news/sionna-therapeutics-sion-stock-looks-pricey-on-assets-but-st","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sion/sionna-therapeutics/news/sionna-therapeutics-sion-stock-looks-pricey-on-assets-but-st","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TSPA","BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652428428","title":"Sionna Therapeutics rises 9.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652428428","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652428428?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:06","pubTimestamp":1784304406,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics (SION) is up 9.2%, or $4.15 to $49.44. Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-rises-9-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-rises-9-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650897282","title":"Orbimed Advisors Disposes of 85,918 Sionna Therapeutics Shares Worth $3.85 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2650897282","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650897282?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:44","pubTimestamp":1783629894,"startTime":"0","endTime":"0","summary":"OrbiMed Advisors disposes of 85,918 Sionna Therapeutics shares worth $3.85 millionOrbiMed Advisors reported selling 85,918 Sionna Therapeutics common shares on July 7, 2026 at USD 44.86.Indirect stake","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDL6SVrls:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Orbimed Advisors Disposes of 85,918 Sionna Therapeutics Shares Worth $3.85 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":113,"code":"91000000","status":"200"}]}}